arrow
G

Giorgio Walter Canonica

humanitas clinical and research center
H指数:127
被引数:7.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Natural Diversity of Grass Pollen in Europe—An EAACI Perspective

欧洲草花粉的自然多样性—<scp>EAACI</scp>观点

2026-10-080
PREAI
Sublingual allergen immunotherapy: evidence from randomized trials, real-world studies and meta-analyses

舌下过敏原免疫疗法:来自随机试验、真实世界研究和荟萃分析的证据

2026-09-150
OA
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases

ARIA-EAACI 2025:气道疾病中以患者为中心、数字化赋能和人工智能辅助的变革管理

2026-09-030
OAAI
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study

易得生物制剂与重症哮喘缓解及其他临床结局的关联:一项全球真实世界研究

2026-08-060
OA
Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden—A SANI Multicenter Cohort

tezepelumab在重症哮喘中的12个月真实世界结局:临床缓解、生物标志物变化和诱因负担——一项SANI多中心队列研究

2026-06-160
OA
Clinical outcomes and remission trajectories in obese and non-obese patients with severe asthma treated with biologics: a retrospective longitudinal cohort study from the Severe Asthma Network Italy (SANI) registry

生物制剂治疗的重度哮喘肥胖与非肥胖患者的临床结局及缓解轨迹:来自意大利重症哮喘网络(SANI)登记研究的回顾性纵向队列研究

2026-05-070
OAAI
Trace Elements in Allergy: Narrative Review

过敏中的微量元素:叙事性综述

2026-05-040
OAAI
Obituary: Sergio Del Giacco (1936–2026)
2026-04-230
PRE
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper

对局部糖皮质激素治疗特应性皮炎及相关皮肤炎症性疾病中反应不足和反应不足的定义:一份GA2LEN ADCARE声明文件

2026-04-150
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
Osteoporosis in Severe Asthmatic Patients: Data from the Severe Asthma Network in Italy (SANI) Registry

严重哮喘患者中的骨质疏松症:来自意大利严重哮喘网络(SANI)登记研究的资料

2026-03-030
OAAI
Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a post hoc analysis of the ANANKE study

严重嗜酸性哮喘的前吸烟者对苯那利珠单抗的反应与从未吸烟者同样有效:ANANKE研究的回顾性分析

2026-02-160
PRE